No Data
Insider holds 14.44% of shares in Kuramoto(5216.JP)
On Nov 5, WANG CHI submitted the Large Shareholding Report to Ministry of Finance to disclose its 14.44% ownership of the shares in $Kuramoto(5216.JP)$. Source: Edinet AnnouncementWhat is the 5%
Insider increases its stake in Kuramoto(5216.JP) to 7.83%
On Nov 5, 那須マテリアル株式会社 submitted the Change Report to Ministry of Finance. The report shows that 那須マテリアル株式会社 increased their holdings in $Kuramoto(5216.JP)$, with their joint shareholding ratio up
Insider decrases its stake in Kuramoto(5216.JP) to 33.16%
On Nov 5, Prolight Corporation Limited submitted the Change Report to Ministry of Finance. The report shows that Prolight Corporation Limited decreased their holdings in $Kuramoto(5216.JP)$, with
October 1st [Today's investment strategy]
[Fisco Selected Stocks] [Material Stocks] Nexera Pharma <4565> 1226 yen (10/1) Drug discovery venture. Former Sosei Group. Its subsidiary Nexera Pharma Japan has announced the signing of a partnership agreement with Shionogi <4507> regarding the distribution and sales of the insomnia treatment drug "Cubick Tablets" in Japan, and resolved its sales efforts with Mochida Pharmaceutical <4534>. Shionogi will independently conduct distribution and sales activities in Japan. [Emerging Markets]
Pay attention to Zojirushi Mahobin and IBJ, Dai Seki, etc. are soft.
In the U.S. stock market on the 1st, the NY Dow Jones Industrial Average closed at 42,156.97, down 173.18 points, the Nasdaq Composite Index closed at 17,910.36, down 278.81 points, and the Chicago Nikkei 225 Futures closed at 38,030 yen, down 740 yen from the Osaka day session. The exchange rate was 1 dollar = 143.50-60 yen. In today's Tokyo market, Zojirushi Mahobin <7965> turned to profit by increasing operating profit for the third cumulative quarter by 6.5% from a 2.4% decrease in the previous period, and announced a share buyback of up to 1.59% of the issued shares.
Kuramoto: Amended temporary report
No Data
No Data